Adult circumcision |
Auvert et al,13 2005 | South Africa | HIV/AIDS incidence, adverse events associated with circumcision | Immediate circumcision | 1,546 | Median 21 y |
| | | Delayed circumcision | 1,582 | Median 21 y |
Bailey et al,14 2007 | Kenya | HIV/AIDS incidence, adverse events associated with circumcision | Immediate circumcision | 1,391 | Median 20 y |
| | | Delayed circumcision | 1,393 | Median 20 y |
Mattson et al,15 2008a | Kenya | Unique data on sexual risk behavior only | Immediate circumcision | 1,391 | Median 20 y |
| | | Delayed circumcision | 1,393 | Median 20 y |
Gray et al,16 2007 | Uganda | HIV/AIDS incidence, adverse events associated with circumcision | Immediate circumcision | 2,474 | Range 15–49 y |
| | | Delayed circumcision | 2,522 | Range 15–49 y |
Kigozi et al,17 2008b | Uganda | Unique data on sexual satisfaction and function only | Immediate circumcision | 2,474 | Range 15–49 y |
| | | Delayed circumcision | 2,522 | Range 15–49 y |
Kigozi et al,18 2008ac | Uganda | Unique data on safety outcomes only | Immediate circumcision | 2,474 | Range 15–49 y |
| | | Delayed circumcision | 2,522 | Range 15–49 y |
Neonatal circumcision |
Macke,19 2001 | USA | Pain distress, mother-infant bonding | Circumcised with acetaminophen | 29 | Mean 29.57±9.18 h |
| | | Circumcised with placebo | 31 | Mean 26.82±6.37 h |
Taddio et al,8 1997 | Canada | Subsequent pain response during vaccination | Uncircumcised | 32 | Mean 133±12.9 d |
| | | Circumcised with EMLA | 20 | Mean 140±23.7 d |
| | | Circumcised with placebo | 26 | Mean 143±29.4 d |